Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate

    • Product Name Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate
    • Alias EMTCP
    • Einecs 684-050-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    462571

    Chemical Name Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate
    Molecular Formula C11H16N2O2S
    Molecular Weight 240.32 g/mol
    Appearance White to off-white solid
    Solubility Soluble in organic solvents like DMSO and methanol
    Cas Number 105137-89-7
    Purity Typically >98% (varies by supplier)
    Storage Conditions Store at 2-8°C, protect from light and moisture

    As an accredited Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical is packaged in a sealed amber glass bottle, labeled clearly, containing 25 grams of Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate.
    Shipping Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-3-carboxylate is shipped in tightly sealed containers, protected from light and moisture. It should be transported at ambient temperature, following all applicable chemical transport regulations, including labeling and documentation. Handle with care, using appropriate safety measures to avoid spillage or exposure during transit.
    Storage Store Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate in a tightly sealed container, protected from light, moisture, and incompatible substances. Keep in a cool, dry, well-ventilated area, ideally at room temperature (15–25°C). Avoid exposure to strong oxidizing agents and acids. Ensure proper chemical labeling and safety protocols are followed to prevent contamination and accidental contact.
    Application of Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate

    Applications of Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate in Industrial Manufacturing

    Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate is widely utilized as a pharmaceutical intermediate, contributing to several high-value downstream sectors with rigorous quality and regulatory demands. As the direct manufacturer, we supply consistent material specifications catering to specialized integrations in drug synthesis, fine chemical development, veterinary compound formulation, and advanced research sectors. Below, we detail key industrial routes where this raw material directly enters downstream value chains.

    1. Human Pharmaceutical Intermediates: Cardiovascular Drug Synthesis

    Major pharmaceutical companies use this compound as an intermediate for developing piperidine-based antihypertensive and antithrombotic agents. It enters the multi-step synthesis process, typically during the cyclization and amination stages, allowing for targeted structural modifications that comply with strict traceability and residual solvent control protocols. Integration supports cGMP batch manufacturing under validated process steps, ensuring trace impurities remain within the thresholds as per ICH guidelines.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • United States Pharmacopeia (USP)/European Pharmacopoeia (EP) specifications for APIs and intermediates
    • FDA 21 CFR Part 211 for finished pharmaceuticals
    • EU EMA GMP guidelines for chemical medicinal products

    Typical usage ratio

    • 0.8–1.5 molar equivalents per target molecule, adjusted based on process yield and downstream purity requirements

    Downstream process integration

    • Introduced during the key intermediate coupling or selective amination phase, followed by purification and characterisation before API finalization

    Final product types

    • Active pharmaceutical ingredients for antihypertensive tablets and capsules
    • Antithrombotic agent APIs for hospital injectable formulations
    • Bulk intermediates for licensed drug substance producers
    • Pre-formulated blends for contract manufacturing organizations (CMOs)

    2. Fine Chemical Synthesis: Chiral Building Block for Specialty Chemicals

    Chemical process manufacturers incorporate this material as a crucial feedstock for the creation of chiral scaffolds and heterocyclic compounds. The distinctive thienopyridine backbone facilitates regioselective functionalization, supporting asymmetric synthesis and the development of advanced intermediates used in commercially valuable agrochemicals and polymer additives. This serves downstream specialty applications where traceability and batch reproducibility play a vital role, often under ISO-certified quality management.

    Industry compliance standards

    • ISO 9001:2015 Quality Management System
    • OECD Good Laboratory Practice (GLP) where required for non-pharma routes
    • REACH registration and safety dossier submission (EU)
    • Product-specific SDS and technical data compliance

    Typical usage ratio

    • 0.5–2.8 wt% relative to total batch mass, varying per synthetic route and required chiral purity

    Downstream process integration

    • Employed at the initial condensation or alkylation stage, enabling further functional group transformations before end product isolation

    Final product types

    • Chiral intermediate stocks for polymer manufacturers
    • Precursor chemicals for high-value agrochemical synthesis
    • Heterocycle-rich chemicals for industrial additive markets
    • Multi-step intermediates for specialty contract synthesis

    3. Veterinary Drug Intermediates

    Veterinary pharmaceutical producers integrate this compound for the synthesis of new animal health products, especially where targeted control of vascular or inflammatory conditions is required. The raw material participates in the functionalization steps of selective veterinary pipeline compounds, adhering to global veterinary compliance and batch trace documentation, to support the safe development of finished veterinary injectables and oral dosages.

    Industry compliance standards

    • VICH GL guidelines for veterinary pharmaceutical substances
    • China Veterinary Pharmacopoeia (CVP) and European Pharmacopoeia (Ph. Eur.) monographs where relevant
    • Traceability documentation for active intermediates under WHO GMP for Veterinary Drugs
    • Animal Drug Master File (DMF) submission protocols (US FDA)

    Typical usage ratio

    • 1.0–1.2 equivalents per product batch, tunable for compound-specific potency and regulatory impurity limits

    Downstream process integration

    • Feeds into the target molecule synthesis after initial acylation or methylation steps, followed by subsequent purification before bulk blending

    Final product types

    • Veterinary oral tablets for anti-inflammatory treatment
    • Parenteral veterinary solutions targeting cardiovascular support
    • Intermediate stock for further chemical modification
    • Animal-use combination products for feed or direct administration

    4. Advanced Pharmaceutical Research and Clinical Candidate Development

    Global pharmaceutical research institutions and R&D divisions purchase this compound as a controlled structure for new molecular entity (NME) programs. It supports early-phase screening, lead optimization, and pilot batch synthesis for investigational drug candidates. Strict project-specific documentation requirements align with research-grade traceability, custom analytical certifications, and parallel GLP compliance for investigational use. Customized lots cater to exploratory medicinal chemistry as well as scale-up feasibility studies.

    Industry compliance standards

    • Good Laboratory Practice (GLP) as defined by OECD/US FDA/EU agencies
    • Project-specific analytical reporting, including NMR and chiral HPLC traceability
    • Research-use only (RUO) status as required by FDA and EU regulators
    • Custom certificate of analysis with structural validation

    Typical usage ratio

    • 0.3–1.0 equivalents per research batch; ratios adjustable for project scale, molecule design, and test screening volume

    Downstream process integration

    • Used at the molecular scaffold assembly stage or as a targeted modifying reagent for analog generation in candidate pipelines

    Final product types

    • Screening compounds for NME research
    • Analytical reference standards
    • Pilot-scale intermediates for later-stage clinical candidate synthesis
    • Structural analog sets for preclinical and SAR studies
    Free Quote

    Competitive Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate: A Closer Look From Our Production Floor

    Every Batch, Every Step: Real Manufacturing of This Specialty Compound

    Working with Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate day in and day out gives us a deep understanding of its quirks, strengths, and the role it plays in research and development. This compound, often requested by pharmaceutical labs and fine chemical innovators, presents unique synthesis challenges compared to more routine esters and pyridine derivatives. From raw material selection to final crystallization, our methods stem from hands-on experience with reaction yields, impurity profiles, and handling techniques, not just what can be read in a textbook.

    Anyone who has stood over a reactor for an amination knows you don’t simply scale up a protocol and expect smooth sailing. Our work with this compound demands more attention at nearly every step. The structure itself—with the thieno[3,2-c]pyridine motif and its multiple substituents—means intermediates often behave unpredictably. Even controlling for the 6-methyl group requires real judgment as methyl branches, if not introduced with precise timing, skew the product spectrum, which impacts purity and downstream utility.

    Model and Specifications: Groundwork Set by Real Production Experience

    We’ve run enough batches to know that anyone expecting textbook yields from the cyclization stage will face issues. The presence of the ethyl ester moiety seems innocent, but temperature ramping, solvent ratio, and quenching speed all play a role in limiting side-chain hydrolysis. Even so, our standard production runs typically achieve yields above 92% on a dry weight basis, with HPLC assay routinely confirming chemical purities above 98%. The melting point sits consistently in our quality range, reflecting both proper reaction control and the quality of starting materials sourced for each batch.

    Moisture content matters more than most realize, especially due to the thieno-pyridine core’s affinity for trace water during post-synthesis storage. To keep specs tight, we limit residual moisture below 0.2%, confirmed batchwise by Karl Fischer titration. Each lot spends hours in vacuum ovens before packing, and no unit gets bagged before it passes weight constancy checks. Controlling particle size isn’t just about aesthetics; labs want reliable dosing, so we run product through precision mills calibrated for the 45-90 micron range. This process, refined over years, creates consistent product flow and helps researchers reproducibly transfer measured aliquots without spillover.

    Real-World Usage: From Lab Benches to Pilot Plants

    In practice, this product finds its way into synthetic routes for various heterocyclic frameworks and modified nucleotides. Its fusion of the tetrahydrothieno ring and the substituted pyridine opens diverse reactivity for medicinal chemistry. Frequent buyers use it as a building block en route to antiviral and anti-inflammatory candidates. From feedback, we know bioactive compound development relies on this material for library expansion: it offers points for functionalization not easily accessible from more common bicyclic systems.

    A few years ago, colleagues at a major research campus shared details about solubility—our batches, compared to competitors’ material, achieve faster dissolution in standard organic solvents. This isn’t accidental. By tightening control over side product cleanup (especially through repeated filtrations and pH adjustments), we minimize the formation of less soluble, partially oxidized byproducts. Our end product, after fine filtration and controlled crystallization, dissolves predictably, which speeds workflow and helps researchers meet synthesis timelines.

    Scale-up in pilot plants often roots out weaknesses missed on a 50-gram scale, and this compound tests process robustness more than most. We’ve learned to avoid chlorinated solvents that degrade the sensitive amino-ester linkage, swinging instead toward greener alternatives like ethyl acetate and acetonitrile when possible. This shift means cleaner downstream workups and fewer complaints about solvent residues from users running green chemistry protocols. Combined with a rigorous system for raw material tracking, we support users who aim for full regulatory traceability in later-stage work.

    Differences That Stem From Real Handling, Not Just Paper Analysis

    Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate often gets lumped in with more basic pyridine esters, but the resemblance ends on paper. The unique fusion of thieno and pyridine rings with partial saturation changes nearly every relevant interaction, both in synthesis and storage. Just opening a new drum and weighing out the product, users often notice lower dusting compared to conventional crystalline pyridines, due to our focus on denser, better-coalesced particles after drying and sieving—a process that demands regular calibration and a nose for shifts in batch texture.

    We’ve seen researchers switching from bulk commercial pyridine esters struggle with reproducibility until they adjust reaction times, especially in nucleophilic substitutions involving the amino function. In contrast to more symmetrical esters, the electron density on this scaffold produces subtle but real effects on reactivity. Downstream transformations (like amide couplings) go faster, and we’ve had direct feedback showing that yields of final products can jump up to 10% over runs using similar, less tailored heterocycles. For teams facing tight research deadlines, these incremental improvements mean fewer reruns and less troubleshooting. A decade ago, achieving this kind of feedback required the hands-on, batch-by-batch process optimization that simply can’t be farmed out to a third-party lab.

    Quality, Purity, and What Makes Our Material Reliable

    Quality isn’t just about hitting a list of standard test results at the end of a batch. Anyone who’s had to scale a process from grams to kilos understands that trace contaminants, even below GC thresholds, can cause ghost peaks or delayed reactions as batch size climbs. From years spent addressing false positives in NMR or patchy reaction kinetics, our process upgrades focus on more than just what’s measured right away. We tweak purification steps based on what we see under real operating pressures—cracking down on batch-to-batch variability, eliminating outlier colors or odors that herald incomplete side product removal.

    To keep purity consistent, we work with suppliers upstream, sometimes demanding extra analytical documentation for high-impact starting materials. Our team doesn’t leave verification to third-party contracts. Each lot gets internal QC—high-resolution mass spectrometry alongside the mandatory HPLC and NMR scanning. This direct hands-on approach pays off; reports from industrial customers confirm longer shelf-life and lower rates of detected impurities during downstream analytics. In some years, we’ve even been asked by customers to validate our material against international reference standards, which we handle using in-house comparison studies.

    Environmental and Safety Considerations on the Production Line

    Working with this compound produces both technical and human challenges. The thieno-based core, particularly during cyclization, yields small quantities of sulfur-containing waste. Rather than sending this straight to disposal, we treat residues on-site using scrubber systems and neutralization steps developed through years of handling volatile sulfur byproducts. This cuts down off-site waste transport, which often brings added responsibility and cost. It helps put safety and environmental concerns front and center, not as an afterthought.

    Anyone who spends time in chemical production facilities knows personal safety isn’t just a checklist. The combination of pyridine-like organics and amines means odors can build rapidly if ventilation isn’t right. We invested in sealed transfer lines and high-velocity extraction hoods early on. The benefits show up in day-to-day operations—fewer odor complaints and much less exposure risk for technicians. It shows why plant layout and airflow, often overlooked, matter as much as any formal compliance document.

    On the downstream end, careful packaging and double sealing are priorities. Shelf-life depends not just on the chemical itself, but on transport stress. Regular shipments to international sites made it obvious that temperature and humidity swings degrade lesser-sealed products. That experience led us to switch to multi-layer foil pouches and insulated drums—a detail that sounds minor until a researcher opens a bag months later and the crystallinity remains as expected.

    Supporting Innovation Beyond Just Supply

    On our end, manufacturing doesn’t finish with the last product packed into drums. Questions from researchers, especially those developing novel drug candidates, often reach us after the fact. Our QC chemists sometimes review users’ reaction schemes, and years of compound handling lets us recognize points where our material’s reactivity or formulation could lead to better yields or fewer side products. By sharing these insights, we support R&D partners in troubleshooting and innovating, beyond just moving inventory.

    Some customers embed our product into patent filings or regulatory submissions for clinical developments. We recognize that reliable sourcing and traceability can decide whether these projects move to the next phase. Delivering not only what meets spec, but what can be documented through comprehensive batch records, raw material trace summaries, and full analytical profiles, supports users who need this documentation with regulators or for technology transfer. Our internal records typically stretch back five years per lot, giving partners assurance if questions arise long after development has moved forward.

    We don’t just react to problems—we use feedback loops from daily operation, lab-scale testing, and customer returns to spot improvement points. For example, we logged observations about color stability: early batches tended toward faint yellowing after extended storage. By tweaking solvent washes and drying profiles, we brought color back to snow-white, which reduces downstream purification for users synthesizing light-sensitive intermediates.

    Continuous Improvement Driven by Hands-On Lessons

    Sometimes, the smallest observations in manufacturing translate into significant value for end users. One case comes to mind: research partners reported unexpected shifts in TLC mobility when comparing our lots to off-the-shelf competitors. Our team traced the difference to subtle variations in particle morphology from dryer configuration, affecting surface hydration and, ultimately, thin-layer separation. Minor? On the surface, maybe. But for high-throughput screening and rapid synthetic cycles, these little improvements reduce variability, making results easier to reproduce. Only years working directly with the material teach those lessons.

    We periodically run internal trials to test how our batches perform under the same conditions our partners use. Running reactions side-by-side using both standard monofunctional esters and this more challenging tetrahydrothieno derivative, we can see first-hand where processes diverge. A pooled comparison of NMR spectra and reactivity rates over dozens of lots gave us technical insights that translated into practical recommendations for customers, saving them hours in optimizing conditions.

    Training the production team emphasizes hands-on learning, not just standard operating procedures. R&D chemists work closely with shift operators, giving everyone an active stake in both process reliability and product improvements. It’s this shared experience that prompts ongoing process upgrades—from better filtration hardware to smarter solvent recovery practices, delivering cleaner product every time.

    Partnering With Researchers: Trust Built Over Time

    Decades of manufacturing this compound have shaped not just our technical methods, but the trust we’ve earned with users who stake their own reputations on every gram we deliver. Customers come back batch after batch because they recognize the difference that a reliable supply chain and transparent feedback process make for complex research.

    Ethyl 2-Amino-6-Methyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine-3-Carboxylate holds a key place in the toolkit of synthetic pharmaceutical and discovery chemistry. Our understanding, rooted in both success and unexpected results, keeps us evolving right alongside scientific progress—not just counting drums in a warehouse. This partnership—built on thousands of weighed samples and careful conversations with science teams worldwide—drives our ongoing commitment to quality, safety, and innovation.